* presence of covid-19 disease manifestations that would require referral for consideration of hospitalization. * a previous positive covid-19 test reported more than 7 days before, which would indicate likelihood of non-culturable, nonreplicating virus. * a positive covid-19 test without a known recent exposure that would indicate an active infection, hence an unknown chance of non-culturable, non-replicating virus being present (i.e., asymptomatic covid-19 infection of unknown duration). * pregnancy or lactation. * known allergic reactions to components of camostat mesylate. * with regard to inclusion or exclusion of women of child-bearing potential, women who report that they know they are pregnant are excluded. all women of child-bearing potential who test positive for pregnancy by urine test at first visit are excluded. a day 14 followup blood pregnancy test will be done on appropriate enrolled women (i.e. those who had a negative urine pregnancy test on day 0 for further safety assessment ).

* presence of covid-19 disease manifestations that would require referral for consideration of hospitalization. * a previous positive covid-19 test reported more than 7 days before, which would indicate likelihood of non-culturable, nonreplicating virus. * a positive covid-19 test without a known recent exposure that would indicate an active infection, hence an unknown chance of non-culturable, non-replicating virus being present (i.e., asymptomatic covid-19 infection of unknown duration). * pregnancy or lactation. * known allergic reactions to components of camostat mesylate. * with regard to inclusion or exclusion of women of child-bearing potential, women who report that they know they are pregnant are excluded. all women of child-bearing potential who test positive for pregnancy by urine test at first visit are excluded. a day 14 followup blood pregnancy test will be done on appropriate enrolled women (i.e. those who had a negative urine pregnancy test on day 0 for further safety assessment ).

- presence of covid-19 disease manifestations that would require referral for consideration of hospitalization. - a previous positive covid-19 test reported more than 7 days before, which would indicate likelihood of non-culturable, nonreplicating virus. - a positive covid-19 test without a known recent exposure that would indicate an active infection, hence an unknown chance of non-culturable, non-replicating virus being present (i.e., asymptomatic covid-19 infection of unknown duration). - pregnancy or lactation. - known allergic reactions to components of camostat mesylate. - with regard to inclusion or exclusion of women of child-bearing potential, women who report that they know they are pregnant are excluded. all women of child-bearing potential who test positive for pregnancy by urine test at first visit are excluded. a day 14 followup blood pregnancy test will be done on appropriate enrolled women (i.e. those who had a negative urine pregnancy test on day 0 for further safety assessment ).

- presence of covid-19 disease manifestations that would require referral for consideration of hospitalization. - a previous positive covid-19 test reported more than 7 days before, which would indicate likelihood of non-culturable, nonreplicating virus. - a positive covid-19 test without a known recent exposure that would indicate an active infection, hence an unknown chance of non-culturable, non-replicating virus being present (i.e., asymptomatic covid-19 infection of unknown duration). - pregnancy or lactation. - known allergic reactions to components of camostat mesylate. - with regard to inclusion or exclusion of women of child-bearing potential, women who report that they know they are pregnant are excluded. all women of child-bearing potential who test positive for pregnancy by urine test at first visit are excluded. a day 14 followup blood pregnancy test will be done on appropriate enrolled women (i.e. those who had a negative urine pregnancy test on day 0 for further safety assessment ).

- presence of covid-19 disease manifestations that would require referral for consideration of hospitalization. - pregnancy or lactation. - known allergic reactions to components of camostat mesylate.

- presence of covid-19 disease manifestations that would require referral for consideration of hospitalization. - pregnancy or lactation. - known allergic reactions to components of camostat mesylate.